Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study

<p>Abstract</p> <p>Background</p> <p>Bisphosphonates are common first line medications used for the management of benign bone disease. One of the most devastating complications associated with bisphosphonate use is osteonecrosis of the jaws which may be related to durat...

Full description

Bibliographic Details
Main Authors: Thomson Wendy, McCullough Michael, Clement John G, Brand Caroline, Borromeo Gelsomina L, Flitzanis Elly, Wark John D
Format: Article
Language:English
Published: BMC 2011-04-01
Series:BMC Musculoskeletal Disorders
Online Access:http://www.biomedcentral.com/1471-2474/12/71
id doaj-b6442100ff8d426abc874e090f654e0d
record_format Article
spelling doaj-b6442100ff8d426abc874e090f654e0d2020-11-24T22:20:18ZengBMCBMC Musculoskeletal Disorders1471-24742011-04-011217110.1186/1471-2474-12-71Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled studyThomson WendyMcCullough MichaelClement John GBrand CarolineBorromeo Gelsomina LFlitzanis EllyWark John D<p>Abstract</p> <p>Background</p> <p>Bisphosphonates are common first line medications used for the management of benign bone disease. One of the most devastating complications associated with bisphosphonate use is osteonecrosis of the jaws which may be related to duration of exposure and hence cumulative dose, dental interventions, medical co-morbidities or in some circumstances with no identifiable aggravating factor. While jaw osteonecrosis is a devastating outcome which is currently difficult to manage, various forms of delayed dental healing may be a less dramatic and, therefore, poorly-recognised complications of bisphosphonate use for the treatment of osteoporosis. It is hypothesised that long-term (more than 1 year's duration) bisphosphonate use for the treatment of post-menopausal osteoporosis or other benign bone disease is associated with impaired dental healing.</p> <p>Methods/Design</p> <p>A case-control study has been chosen to test the hypothesis as the outcome event rate is likely to be very low. A total of 54 cases will be recruited into the study following review of all dental files from oral and maxillofacial surgeons and special needs dentists in Victoria where potential cases of delayed dental healing will be identified. Potential cases will be presented to an independent case adjudication panel to determine if they are definitive delayed dental healing cases. Two hundred and fifteen controls (1:4 cases:controls), matched for age and visit window period, will be selected from those who have attended local community based referring dental practices. The primary outcome will be the incidence of delayed dental healing that occurs either spontaneously or following dental treatment such as extractions, implant placement, or denture use.</p> <p>Discussion</p> <p>This study is the largest case-controlled study assessing the link between bisphosphonate use and delayed dental healing in Australia. It will provide invaluable data on the potential link between bisphosphonate use and osteonecrosis of the jaws.</p> http://www.biomedcentral.com/1471-2474/12/71
collection DOAJ
language English
format Article
sources DOAJ
author Thomson Wendy
McCullough Michael
Clement John G
Brand Caroline
Borromeo Gelsomina L
Flitzanis Elly
Wark John D
spellingShingle Thomson Wendy
McCullough Michael
Clement John G
Brand Caroline
Borromeo Gelsomina L
Flitzanis Elly
Wark John D
Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
BMC Musculoskeletal Disorders
author_facet Thomson Wendy
McCullough Michael
Clement John G
Brand Caroline
Borromeo Gelsomina L
Flitzanis Elly
Wark John D
author_sort Thomson Wendy
title Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
title_short Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
title_full Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
title_fullStr Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
title_full_unstemmed Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
title_sort is bisphosphonate therapy for benign bone disease associated with impaired dental healing? a case-controlled study
publisher BMC
series BMC Musculoskeletal Disorders
issn 1471-2474
publishDate 2011-04-01
description <p>Abstract</p> <p>Background</p> <p>Bisphosphonates are common first line medications used for the management of benign bone disease. One of the most devastating complications associated with bisphosphonate use is osteonecrosis of the jaws which may be related to duration of exposure and hence cumulative dose, dental interventions, medical co-morbidities or in some circumstances with no identifiable aggravating factor. While jaw osteonecrosis is a devastating outcome which is currently difficult to manage, various forms of delayed dental healing may be a less dramatic and, therefore, poorly-recognised complications of bisphosphonate use for the treatment of osteoporosis. It is hypothesised that long-term (more than 1 year's duration) bisphosphonate use for the treatment of post-menopausal osteoporosis or other benign bone disease is associated with impaired dental healing.</p> <p>Methods/Design</p> <p>A case-control study has been chosen to test the hypothesis as the outcome event rate is likely to be very low. A total of 54 cases will be recruited into the study following review of all dental files from oral and maxillofacial surgeons and special needs dentists in Victoria where potential cases of delayed dental healing will be identified. Potential cases will be presented to an independent case adjudication panel to determine if they are definitive delayed dental healing cases. Two hundred and fifteen controls (1:4 cases:controls), matched for age and visit window period, will be selected from those who have attended local community based referring dental practices. The primary outcome will be the incidence of delayed dental healing that occurs either spontaneously or following dental treatment such as extractions, implant placement, or denture use.</p> <p>Discussion</p> <p>This study is the largest case-controlled study assessing the link between bisphosphonate use and delayed dental healing in Australia. It will provide invaluable data on the potential link between bisphosphonate use and osteonecrosis of the jaws.</p>
url http://www.biomedcentral.com/1471-2474/12/71
work_keys_str_mv AT thomsonwendy isbisphosphonatetherapyforbenignbonediseaseassociatedwithimpaireddentalhealingacasecontrolledstudy
AT mcculloughmichael isbisphosphonatetherapyforbenignbonediseaseassociatedwithimpaireddentalhealingacasecontrolledstudy
AT clementjohng isbisphosphonatetherapyforbenignbonediseaseassociatedwithimpaireddentalhealingacasecontrolledstudy
AT brandcaroline isbisphosphonatetherapyforbenignbonediseaseassociatedwithimpaireddentalhealingacasecontrolledstudy
AT borromeogelsominal isbisphosphonatetherapyforbenignbonediseaseassociatedwithimpaireddentalhealingacasecontrolledstudy
AT flitzaniselly isbisphosphonatetherapyforbenignbonediseaseassociatedwithimpaireddentalhealingacasecontrolledstudy
AT warkjohnd isbisphosphonatetherapyforbenignbonediseaseassociatedwithimpaireddentalhealingacasecontrolledstudy
_version_ 1725775827522551808